Get started
Author

Maaike de Fost

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
2003 · Rolf G. Boot, Marri Verhoek, et al. · Blood · 331
PDF
Increased incidence of cancer in adult Gaucher disease in Western Europe
2005 · M. de Fost, S. vom Dahl, et al. · Blood Cells Molecules and Diseases · 188
Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis
2006 · Maaike de Fost, Carla E. M. Hollak, et al. · Blood · 143
Increased plasma macrophage inflammatory protein (MIP)-1α and MIP-1β levels in type 1 Gaucher disease
2007 · Mariëlle J. van Breemen, Maaike de Fost, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 116
PDF
Plasma level of the macrophage‐derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease
2004 · Holger Jon Møller, Maaike de Fost, et al. · European Journal Of Haematology · 103
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature
2008 · M. de Fost, T. A. Out, et al. · Annals of Hematology · 102
PDF
Recommendations for the management of the haematological and onco‐haematological aspects of Gaucher disease1
2007 · Derralynn Hughes, Maria Domenica Cappellini, et al. · British Journal of Haematology · 89
Overweight, insulin resistance and type II diabetes in type I Gaucher disease patients in relation to enzyme replacement therapy
2007 · M. Langeveld, M.de Fost, et al. · Blood Cells Molecules and Diseases · 62
Persistent bone disease in adult type 1 Gaucher disease despite increasing doses of enzyme replacement therapy
2008 · M. de Fost, C. J.M. van Noesel, et al. · Haematologica · 57
PDF
Differential expression of interferon-γ and interferon-γ-inducing cytokines in Thai patients with scrub typhus or leptospirosis
2004 · Wirongrong Chierakul, Maaike de Fost, et al. · Clinical Immunology · 54
Activation of Cytotoxic Lymphocytes in Patients With Scrub Typhus
2005 · MAAIKE DE FOST, WIRONGRONG CHIERAKUL, et al. · American Journal of Tropical Medicine and Hygiene · 45
Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease
2008 · M. de Fost, M. Langeveld, et al. · Atherosclerosis · 41
Gaucher disease: from fundamental research to effective therapeutic interventions.
2003 · M de Fost, J M F G Aerts, et al. · PubMed · 41
Interleukin 12 in Part Regulates Gamma Interferon Release in Human Whole Blood Stimulated withLeptospira interrogans
2003 · Maaike de Fost, Rudy A. Hartskeerl, et al. · Clinical and Vaccine Immunology · 39
The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsia
2015 · M de Fost, S M Oussaada, et al. · Endocrine Connections · 30
PDF
Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial
2007 · M. de Fost, J. M.F.G. Aerts, et al. · Haematologica · 29
PDF
Release of granzymes and chemokines in Thai patients with leptospirosis
2006 · M. De Fost, W. Chierakul, et al. · Clinical Microbiology and Infection · 24
Enzyme therapy for the treatment of type 1 Gaucher disease: clinical outcomes and dose – response relationships
2009 · Carla EM Hollak, Maaike de Fost, et al. · Expert Opinion on Pharmacotherapy · 21
Familial neurohypophyseal diabetes insipidus due to a novel mutation in the arginine vasopressin–neurophysin II gene
2011 · M de Fost, A S P van Trotsenburg, et al. · European Journal of Endocrinology · 18
Low-dose versus high-dose therapy for Gaucher disease: goals and markers
2007 · Carla E. M. Hollak, Maaike de Fost, et al. · Blood · 8
PDF
Different dose‐dependent correction of MIP‐1β and chitotriosidase during initial enzyme replacement therapy
2009 · M. J. van Breemen, M. de Fost, et al. · Journal of Inherited Metabolic Disease · 7
The blood–brain barrier and treatment of lysosomal storage diseases
2005 · J.M. Aerts, M.J. van Breemen, et al. · International Congress Series · 3
Chapter Three Chapter Three Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention
2008 · Erasmus Mc, Rolf G. Boot, et al.
Gaucher disease type I : associated morbidities and long term efficacy of enzyme replacement therapy
2008 · Maaike de Fost · UvA-DARE (University of Amsterdam)
Gaucher disease type 1; associated morbidities and long term efficcacy of enzyme replacement therapy
2008 · de Fost, Maaike, Hollak, C.E.M. · Pure Amsterdam UMC
Works count: 31
Citation count: 1,551
H-index: 18
I10-index: 19
Year
Topic
Type